미생물 동정 시장 보고서 : 제품 및 서비스별, 기술별, 방법별, 용도별, 지역별(2026-2034년)

The global microbial identification market size reached USD 5.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2034, exhibiting a growth rate (CAGR) of 9.24% during 2026-2034. There are several factors that are driving the market, which include the increasing focus on food safety testing, expansion of the pharmaceutical and biotechnology industries, and rising need for environmental monitoring in water treatment and waste management.

MICROBIAL IDENTIFICATION MARKET ANALYSIS:

• Major Market Drivers: One of the key market drivers include the introduction of advanced technologies. Moreover, there is an increase in the prevalence of infectious diseases among individuals, which is acting as another growth-inducing factor.
• Key Market Trends: The rising need for environmental monitoring in water treatment and waste management and the expansion of the pharmaceutical and biotechnology industries are main trends in the market.
• Geographical Trends: North America exhibits a clear dominance, accounting for the biggest market share owing to the well-developed healthcare infrastructure.
• Competitive Landscape: Numerous major market players in the microbial identification industry are Beckman Coulter Inc., Biolog, BioMerieux, Bruker Corporation, Charles River Laboratories Inc., Eurofins Scientific, Liofilchem S.r.l, Shimadzu Corporation, Thermo Fisher Scientific Inc., Wickham Micro Limited, among many others.
• Challenges and Opportunities: High cost of advanced technologies represent a key market challenge. Nonetheless, the development of more efficient, accurate, and cost-effective microbial identification techniques, coupled with collaborations and partnerships among industry players, is projected to conquer these challenges and provide market opportunities.

MICROBIAL IDENTIFICATION MARKET TRENDS:

Expansion of the Pharmaceutical and Biotechnology Industries

Microbial identification is vital in biotechnology and pharmaceutical sectors for numerous reasons. Ensuring the absence of microbiological contamination in pharmaceutical goods is crucial for both regulatory compliance and patient safety. During manufacturing operations, microbiological identification aids in the monitoring and management of contamination. Extensive microbiological testing is necessary to understand interactions, effects, and safety profiles while developing novel medications and biotechnological products. In addition, sterility testing and monitoring of bioreactors and fermentation processes maintain product integrity and efficacy, which is supporting the microbial identification market growth. Furthermore, pharmaceutical industry players are investing in microbial identification testing to ensure enhanced drug efficacy. For instance, on 31 May 2023, Merck, a leading science and technology company, invested € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe and efficacy while meeting regulatory requirements.

Rising Focus on Food Safety Testing

The IMARC Group estimated that the global market for food safety testing accounted for US$ 23.2 billion in 2023. The food and beverage (F&B) industry is focusing on ensuring product safety and compliance with regulatory standards, which is catalyzing the microbial identification demand. To avoid foodborne infections, it is essential to make sure that food products are free of dangerous germs including Salmonella, E. Coli, Listeria, and Campylobacter. Microbial testing benefits in the early identification and removal of these infections. Thorough microbiological testing and documentation are necessary to comply with food safety requirements issued by organizations such as the European Food Safety Authority (EFSA), the Food and Drug Administration (FDA), and other bodies. Furthermore, identifying spoilage microorganisms are beneficial in determining the shelf life of food items. Accurate microbial identification allows producers to optimize packaging to extend shelf life of food products.

Increasing Need for Environmental Monitoring and Testing in Water Treatment

The growing need for environmental monitoring in water treatment and waste management to detect and control microbial contamination is offering a favorable microbial identification market outlook. There is a rise in the focus on ensuring the safety and quality of drinking water. Microbial contamination in water sources can lead to severe health issues, prompting the need for regular monitoring to detect pathogens like E. coli, Legionella, and Cryptosporidium. Efficient wastewater treatment processes require continuous monitoring to prevent the spread of harmful microorganisms into the environment. Identifying and controlling microbial contamination in wastewater is crucial for environmental protection and public health. Besides this, companies are investing in microbial identification products that are specially designed for water treatment applications. For example, on 18 August 2023, Lovibond(R) introduced test kits that are designed for industrial use. They include all necessary test equipment, tools, and reagents required for monitoring boiler and cooling water, open and closed water systems, or disinfection. They cover chemical and microbiological parameters essential in industrial water applications such as biofilm, corrosion, scale, and raw water treatment.

MICROBIAL IDENTIFICATION MARKET SEGMENTATION:

Breakup by Products and Services:

• Instruments and Software
• Consumables
  • Panels/ID Cards and Media
  • Kits
  • Others
• Services

Instruments and software are frequently utilized for quick and precise microbial identification. Polymerase chain reaction (PCR) instruments are necessary for amplifying and detecting microbial deoxyribonucleic acid (DNA). In addition, sophisticated software is employed to analyze the intricate microbiological data produced by devices.

Panels, ID cards, medium, and kits for identifying microbes are examples of consumables. PCR kits are made to identify microorganisms through the use of PCR technology. Additionally, pathogen detection kits are essential for quickly identifying pathogens in a variety of samples. Enzyme-linked immunosorbent assay (ELISA) kits are also used to detect antibodies and microbiological antigens.

In order to guarantee precise and dependable operation, services are used for instrument calibration and maintenance. Specialized laboratories offer outsourced services for the identification of microbiological organisms in various samples. In addition, there is a rise in the employment of professional services for analyzing and interpreting complex microbial data.

Breakup by Technology:

• Mass Spectrometry
• PCR
• Flow Cytometry
• Microscopy

Mass spectrometry holds the largest share of the industry

Microorganisms can be quickly and accurately identified using mass spectrometry. Mass spectrometry can recognize a broad variety of bacteria, fungus, and other microorganisms in a few minutes. Large microbial libraries support it and improve its capacity to recognize a wide range of bacteria. Furthermore, mass spectrometry systems are economical over time as compared to other methods because they have a low sample cost. They can analyze multiple types of samples including clinical specimens, environmental samples, and food products. They can be integrated with other identification technologies and laboratory information management systems (LIMS) to enhance their utility in various applications, which is projected to lead to a positive microbial identification market forecast.

Breakup by Method:

• Phenotypic Methods
• Genotypic Methods
• Proteomics-Based Methods

Phenotypic methods represent the leading market segment

Phenotypic methods including biochemical tests, culture-based techniques, and morphological assessments offer proven reliability. These methods are more cost-effective as compared to genotypic or mass spectrometry techniques. They often require less expensive equipment and reagents, making them accessible to a wider range of laboratories including those with limited budgets. They are relatively simple to perform and do not require specialized training or sophisticated instrumentation. This ease of use facilitates their widespread adoption, especially in resource-limited settings.

Breakup by Application:

• Diagnostics
• Food and Beverage Testing
• Pharmaceuticals
• Cosmetics and Personal Care Products Testing

The rising utilization of microbial identification in clinical diagnostics is bolstering the market growth. Rapid and accurate identification of pathogens helps in selecting appropriate treatments and managing patient care. Identifying and monitoring hospital-acquired infections (HAIs) is essential for preventing outbreaks and ensuring patient safety. Monitoring and identifying microbial pathogens in the community helps in controlling the spread of infectious diseases and managing public health crises.

There is an increase in the need for microbial identification in food and beverage testing to prevent foodborne illnesses and ensure consumer safety. Regular microbial testing helps in maintaining the quality of food products by detecting spoilage organisms and ensuring compliance with food safety standards. Adhering to food safety regulations set by various agencies requires rigorous microbial testing and documentation.

It is critical for patient safety and regulatory compliance that pharmaceutical products are free from microbial contamination. Regular sterility testing of pharmaceutical products including injectable drugs and medical devices, is essential to prevent infections. Identifying and controlling microbial contamination in biopharmaceutical production processes such as fermentation is critical for product safety and efficacy.

Cosmetics and personal care products testing are vital for identifying microbial contamination and extending the shelf-life of cosmetics products while ensuring they remain safe for use over time. Regular microbial testing during the production of cosmetics helps maintain product quality and consistency.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest microbial identification market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for microbial identification.

North America, particularly the United States and Canada, has a well-developed healthcare infrastructure that supports extensive use of microbial identification technologies for clinical diagnostics and hospital infection control. The region experiences a significant burden of infectious diseases, which is catalyzing the need for rapid and accurate microbial identification to manage and treat these conditions effectively. In addition, strict regulatory requirements for food safety, pharmaceuticals, and environmental monitoring necessitate rigorous and effective testing, thereby influencing microbial identification industry trends in the region. Apart from this, key market players in the North American region are focusing on expanding their reach by engaging in partnerships and collaborations and opening new research centers. For instance, on 28 June 2023, Eurofins|CRL announced the grand opening of a new microbiology laboratory in Austin, Texas, to expand both the capacity and capabilities of its microbiology department. The new microbiology laboratory is focused on preservative efficacy testing (PET), quality control, and stability testing of cosmetics and personal care products.

COMPETITIVE LANDSCAPE:

Top players in the market are investing in research and development (R&D) for innovative and more efficient microbial identification technologies. This includes advancements in next-generation sequencing (NGS) and PCR-based methods. They are developing automated systems and integrating artificial intelligence (AI) and machine learning (ML) for data analysis and interpretation to enhance the accuracy and speed of microbial identification. They are also unveiling new facilities to increase their market presence. For instance, on 14 August 2023, American Institute of Pathology & Laboratory Sciences Pvt Ltd (AMPATH) opened its first reference laboratory in Gurgaon as part of its expansion plans in North India. The 7000 sq. ft. laboratory is equipped with the latest technology platforms capable of delivering quality reports with a quick Turn-Around-Time (TAT). The lab offers diagnostic tests in clinical biochemistry, hematology, flow cytometry, clinical pathology, serology, immunology, microbiology, cytology, histopathology, immunohistochemistry, molecular diagnosis, NGS, and cytogenetics.

The report provides a comprehensive analysis of the competitive landscape in the global microbial identification market with detailed profiles of all major companies, including:

• Beckman Coulter Inc.
• Biolog
• BioMerieux
• Bruker Corporation
• Charles River Laboratories Inc.
• Eurofins Scientific
• Liofilchem S.r.l
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Wickham Micro Limited

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Microbial Identification Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Products and Services

• 6.1 Instruments and Software
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Panels/ID Cards and Media
    • 6.2.2.2 Kits
    • 6.2.2.3 Others
  • 6.2.3 Market Forecast
• 6.3 Services
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Technology

• 7.1 Mass Spectrometry
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 PCR
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Flow Cytometry
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Microscopy
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Method

• 8.1 Phenotypic Methods
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Genotypic Methods
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Proteomics-Based Methods
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Application

• 9.1 Diagnostics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Food and Beverage Testing
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Pharmaceuticals
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Cosmetics and Personal Care Products Testing
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Others
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Beckman Coulter Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 SWOT Analysis
  • 15.3.2 Biolog
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 BioMerieux
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Bruker Corporation
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Charles River Laboratories Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Eurofins Scientific
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Liofilchem S.r.l
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Shimadzu Corporation
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Thermo Fisher Scientific Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Wickham Micro Limited
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio